- Home
- RLYB vs SNES Comparison
RLYB vs SNES Comparison
Compare RLYB & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLYB
- SNES
- Stock Information
- Founded
- RLYB 2018
- SNES 2004
- Country
- RLYB United States
- SNES United States
- Employees
- RLYB N/A
- SNES N/A
- Industry
- RLYB Biotechnology: Pharmaceutical Preparations
- SNES Agricultural Chemicals
- Sector
- RLYB Health Care
- SNES Industrials
- Exchange
- RLYB Nasdaq
- SNES Nasdaq
- Market Cap
- RLYB 22.0M
- SNES 21.0M
- IPO Year
- RLYB 2021
- SNES 2016
- Fundamental
- Price
- RLYB $0.63
- SNES $4.60
- Analyst Decision
- RLYB Hold
- SNES Strong Buy
- Analyst Count
- RLYB 3
- SNES 1
- Target Price
- RLYB $15.00
- SNES $10.00
- AVG Volume (30 Days)
- RLYB 458.7K
- SNES 146.6K
- Earning Date
- RLYB 08-07-2025
- SNES 08-07-2025
- Dividend Yield
- RLYB N/A
- SNES N/A
- EPS Growth
- RLYB N/A
- SNES N/A
- EPS
- RLYB N/A
- SNES N/A
- Revenue
- RLYB $761,000.00
- SNES $2,093,000.00
- Revenue This Year
- RLYB N/A
- SNES $130.53
- Revenue Next Year
- RLYB N/A
- SNES $22.87
- P/E Ratio
- RLYB N/A
- SNES N/A
- Revenue Growth
- RLYB 154.51
- SNES 36.89
- 52 Week Low
- RLYB $0.22
- SNES $1.30
- 52 Week High
- RLYB $1.25
- SNES $6.24
- Technical
- Relative Strength Index (RSI)
- RLYB 64.03
- SNES 46.41
- Support Level
- RLYB $0.53
- SNES $4.47
- Resistance Level
- RLYB $0.65
- SNES $4.88
- Average True Range (ATR)
- RLYB 0.06
- SNES 0.31
- MACD
- RLYB 0.00
- SNES -0.08
- Stochastic Oscillator
- RLYB 90.44
- SNES 22.16
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.